Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06118905

Preserving Geriatric Muscle With an Osteoporosis Medication

Sponsor: Susan L. Greenspan

Interventions Denosumab 60 MG/ML Zoledronic Acid 5Mg/Bag 100Ml Infusion

Updated 8 times since 2023 Last updated: Feb 9, 2026 Started: Feb 8, 2024 Primary completion: Feb 28, 2029 Completion: Mar 31, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Osteoporosis and is currently actively recruiting participants. Susan L. Greenspan leads this study, which shows 8 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Recruiting PHASE4
Apr 2025 — Feb 2026 [monthly]

Recruiting PHASE4
Mar 2025 — Apr 2025 [monthly]

Recruiting PHASE4
Sep 2024 — Mar 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4

▶ Show 3 earlier versions

Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE4
Feb 2024 — Apr 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Dec 2023 — Feb 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Susan L. Greenspan

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States